Red List

ORKAOruka Therapeutics, Inc.

Healthcare · Biotechnology · mid-cap ($3.6B)
-36.3%
from rolling 252-day high of $91.00 set 2026-04-27 · 31d ago
Current
$57.98
Decline depth
-36.3%
Decline σ
5.1σ
TFC
1/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$ORKA landed on the list 2026-05-26, down 35.1% from its 52-week high that day — now down -36.3%.

It has clawed back 11.9 percentage points off that level. It bottomed 39.5% below that high along the way.

Decline from the 52-week high as it stood on 2026-05-26 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

ORKA qualifies for the Red List on decline depth.

Decline depth
-36.3%
From rolling 252-day high of $91.00, 31d ago. Past the 30% Amber threshold.
Time-frame continuity
1/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
5.1σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (3.99% per day). Past the ≥4σ Watch threshold.

The structural read

What price action says about ORKA.

ORKA qualifies for the Red List on decline depth — down -36.3% from its rolling 252-day high. Past 30% with the high set inside the last four months — the recency clause that often precedes further breakdown. Depth plus recency: this is the pattern many investors call a falling knife.

Cross-confirmation: decline sigma also reads 5.1σ over 20 bars.

Earnings on file: 2026-05-13. Tiering is unaffected by earnings dates — listings reflect price structure only.

52-week range

52W low $10.64 58.9% of range 52W high $91.00

Sector context · Healthcare

194 other Healthcare tickers are on Broken Stocks.

88 Red List
47 Amber
59 Watch
-35.8% Median decline

Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →

Questions about ORKA

What people ask.

Why is ORKA on Broken Stocks?

ORKA qualifies for the Red List on decline depth. It is down -36.3% from its rolling 252-day high of $91.00, set on 2026-04-27 — 31d ago.

Is ORKA a falling knife?

By the most common technical definition — a steep, recent breakdown from a fresh high — yes. ORKA is down -36.3% from its 52-week high of $91.00, set 31d ago. That combination of depth (past the 30% Amber threshold) and recency (high set inside the last 120 days) is the textbook falling-knife pattern. Whether to try to catch it is a separate question — historically most attempts to bottom-pick continue lower before reversing. Broken Stocks flags the pattern; it does not recommend buying or selling.

Is ORKA a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is ORKA trading inside its 52-week range?

At $57.98, ORKA sits 58.9% of the way from its 52-week low ($10.64) to its 52-week high ($91.00). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has ORKA been declining?

The current 36.3% decline accrued over 31d, which annualizes to roughly -427.4% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does ORKA compare to its sector?

There are 194 other Healthcare tickers on Broken Stocks: 88 Red, 47 Amber, 59 Watch, with 108 showing recovering structural signals. Median sector decline is -35.8% — ORKA's decline is deeper than the sector median.

Does ORKA's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-13) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.